GRFS — Grifols, S.A. stock price, charts and financials

QT42Grifols, S.A.

Grifols, S.A. (NASDAQ: GRFS) is a Healthcare company in the Drug Manufacturers - General industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
8.05
+0.11+1.39%
OverviewShort InterestFilings
GRFSQT42Grifols, S.A.·NASDAQ
8.05+1.39%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 30, 20266-KForeign issuer report
Jul 29, 20266-KForeign issuer report
Jun 22, 20266-KForeign issuer report
Jun 18, 20266-KForeign issuer report
May 15, 20266-KForeign issuer report
May 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 07, 20266-KForeign issuer report
Apr 17, 202620-FAnnual report (foreign issuers)
Apr 14, 20266-KForeign issuer report
Mar 24, 20266-KForeign issuer report
Feb 26, 20266-KForeign issuer report
Feb 26, 20266-KForeign issuer report
Feb 17, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Feb 12, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jan 08, 20266-KForeign issuer report
Dec 16, 20256-KForeign issuer report
Nov 12, 2025SC 13G/ABeneficial ownership statement (passive, amended)
Nov 04, 20256-KForeign issuer report
Sep 29, 20256-KForeign issuer report
Jul 30, 20256-KForeign issuer report
Jul 29, 20256-KForeign issuer report
Jul 29, 20256-KForeign issuer report
Jun 12, 20256-KForeign issuer report
Jun 05, 20256-KForeign issuer report
May 12, 20256-KForeign issuer report
#1 / 25 of 142
Page
▼
/ 6